Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-237275
Filing Date
2025-10-10
Accepted
2025-10-10 18:45:57
Documents
1
Period of Report
2025-10-08

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 8879
  Complete submission text file 0001193125-25-237275.txt   11385
Mailing Address NEWTONLAAN 91 PO BOX 85067 3508 UTRECHT Netherlands
Business Address NEWTONLAAN 91 PO BOX 85067 3508 UTRECHT Netherlands 31(0)30-2192549
Gilde Healthcare Holding B.V. (Reporting) CIK: 0001420106 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40241 | Film No.: 251388951

Mailing Address NEWTONLANN 51 PO BOX 85067 UTRECHT Netherlands
Business Address NEWTONLANN 51 PO BOX 85067 UTRECHT Netherlands 949-396-6322
Cooperatieve Gilde Healthcare IV U.A. (Reporting) CIK: 0001756335 (see all company filings)

State of Incorp.: P7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-40241 | Film No.: 251388952

Mailing Address YALELAAN 62 UTRECHT Netherlands
Business Address YALELAAN 62 UTRECHT Netherlands 31 6 3000 3035
LAVA Therapeutics NV (Issuer) CIK: 0001840748 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)